News

Organigram Provides Edison JOLTS Product Update

March 13, 2023

TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced that it has received notification from Health Canada that Health Canada has determined that certain Jolts lozenge products in their 100 mg THC per package format (the “Products”) have been improperly classified as an “extract” rather than an “edible” under the Cannabis Regulations. The Company launched the Products in August 2021 following significant research, development and r

Details

Kanabo Group Launches ‘Treat It’ – UK’s First Online Medicinal Cannabis Clinic For Chronic Pain Management

March 13, 2023

LONDON–(BUSINESS WIRE)–Kanabo Group today announced the launch of Treat It the UK’s first online medical cannabis clinic for pain management. Treat It solves the problem faced by millions of chronic pain sufferers in the UK whose conventional pharmaceutical treatments are not working or are frustrated by long wait times to be referred for treatment. Built on a unique health tech platform, which accesses the patient’s medical record, Treat It is able to provide high-quality treatments quickly

Details

gamma and Entertainment Icon Snoop Dogg Announce Today’s Arrival of the Death Row Records Catalog to All Streaming Services Worldwide

March 10, 2023

LOS ANGELES–(BUSINESS WIRE)–gamma and Snoop Dogg celebrate today’s arrival of the Death Row Records catalog, inclusive of music and videos, to all streaming services worldwide. This partnership is designed as a long-term licensing agreement which provides gamma with the exclusive worldwide rights to market and distribute the Death Row Records catalog. Vydia, recently acquired by gamma, will distribute the music exclusively. Additionally, gamma will also release two new albums from Snoop Dogg

Details

Haymarket Media Acquires the American Journal of Endocannabinoid Medicine

March 9, 2023

NEW YORK–(BUSINESS WIRE)–Haymarket Media, Inc. is pleased to announce that it has acquired the American Journal of Endocannabinoid Medicine (AJEM)—a peer-reviewed journal focused on cannabinoid medicine. Haymarket is making an additional investment in AJEM to increase its engagement with healthcare professionals (HCPs) and fulfill its mission to educate and inform the medical community on cannabinoid-based therapy. Physicians are not trained in the endocannabinoid system (ECS) in medical scho

Details

Unity Rd. Signs First Agreement For Future Cannabis Establishment in the Green Mountain State

March 9, 2023

BURLINGTON, Vt.–(BUSINESS WIRE)—- $INLB #cannabis–Unity Rd. signed its first agreement to bring a cannabis establishment to Vermont, further expanding its presence in the Northeast region of the U.S.

Details

2021 Pro Football Hall of Famer, Calvin Johnson Jr. Announces His Wellness Company Primitiv Group Will Open a Boston-Based Cannabis Dispensary In 2023

March 9, 2023

DETROIT–(BUSINESS WIRE)–Primitiv, a Michigan-based cannabis company founded by former NFL teammates, Rob Sims, and 2021 Pro Football Hall of Fame inductee, Calvin Johnson Jr., today announced Primitiv Boston, a wellness-focused cannabis dispensary opening soon on High Street in Boston’s Waterfront District. Primitiv Boston is a collaboration with Johnson and Sims’ cannabis and wellness brand, Primitiv, and the duo’s former Detroit Lions teammate and Boston College alumnus, Gosder Cherilus, al

Details

Relm Insurance Announces Strategic Partnership with Cyber Risk Management Firm NetDiligence®

March 9, 2023

BERMUDA–(BUSINESS WIRE)– #cryptocurrency–Relm Insurance Ltd. (Relm), a specialty insurance carrier serving innovative industries, today announced a partnership with NetDiligence®, a leading provider of cyber risk readiness and response services, to deliver a suite of cyber risk monitoring solutions to policyholders via automated enrollment through NetDiligence’s eRiskHub®. “Effective cyber risk management is no longer optional — it’s essential. As cyber threats continue to evolve, our policyholders must stay

Details

Pyramid enters the Canadian market with key leadership hires, inks partner agreements with top Canada-based technology consultants

March 9, 2023

LONDON, NEW YORK CITY & TEL AVIV, Israel–(BUSINESS WIRE)–Pyramid enters the Canadian market with key leadership hires and inks partner agreements with top Canada-based technology consultants, MIS3 and THC.

Details

The 420 Hotels Announces Launch of Crowdfunding Round for the First Hotel With a Legally Licensed Lounge for Cannabis Consumption

March 9, 2023

DENVER–(BUSINESS WIRE)–The 420 Hotels Inc. is entering the next phase of opening Denver’s first legally licensed cannabis consumption lounge in a boutique hotel by announcing the launch of an equity crowdfunding campaign and by filing their Form C with the SEC through StartEngine, an industry leading private investment platform for investors seeking high growth potential in highly vetted, early stage ventures. This campaign is now live, and according to the Form C, this is the first time a li

Details

National Survey Reveals More Than One-Third of U.S. Women Consume Cannabis, But Stigmas Linger

March 8, 2023

LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today released the results of a new national survey examining the cannabis consumption habits of American women. The survey, conducted online by The Harris Poll on behalf of MedMen, found that more than one-third (37%) of American women aged 21+ consume cannabis, and more than one in four (28%) say they use cannabis

Details

Akanda Corporation Announces 1-for-10 Reverse Stock Split

March 8, 2023

LONDON–(BUSINESS WIRE)–International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) an Ontario company, reported that it expects to implement a 1-for-10 reverse stock split on its ordinary shares effective Thursday March 9, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary shares will continue on the Nasdaq Capital Market under the symbol “AKAN”. The new CUSIP number for the ordinary shares follow

Details

MyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent Trolls

March 8, 2023

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious and debilitating autoimmune and inflammatory diseases, today announced that it has joined LOT Network, the international, non-profit community of companies working together to protect themselves against litigation brought on by patent assertion entities (PAEs, also known as “patent trolls”).

Details